News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical
Friday, September 13, 2024Turbine the biological simulation company using AI to build a digital lab for predictive computational models of human cells and tissue today announced that Ono Pharmaceutical
Roche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
Thursday, September 12, 2024Roche announced the opening of its new Pharma Research and Early Development pRED Center at its global headquarters in Basel Switzerland Equipped with cuttingedge technologies
Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
Thursday, September 12, 2024Actuate Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing therapies for the treatment of highimpact difficulttotreat cancers through the inhibition of glycogen synthase kinase beta
Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe
Wednesday, September 11, 2024Santhera Pharmaceuticals announces the signing of an exclusive distribution agreement with GENESIS Pharma for AGAMREE vamorolone for the treatment of Duchenne muscular dystrophy DMD in markets in Central and Eastern
Somite Therapeutics and OmniaBio Inc. Announce Partnership to Advance Somite's Cell Therapy Flagship Program
Tuesday, September 10, 2024Somite Therapeutics a techbio company harnessing big data and AI to pioneer novel cell replacement therapies and OmniaBio Inc a technologydriven cell and gene therapy CDMO founded by CCRM today announced a cell therapy development and manufacturing
AISA Pharma Receives FDA Orphan Drug Designation for AISA-021 for Treatment of Systemic Sclerosis
Tuesday, September 10, 2024Aisa Pharma Inc a private clinicalstage biopharmaceutical company announced that the US Food and Drug Administration FDA has granted orphan drug designation to AISAcilnidipine a fourthgeneration calcium channel antagonis
Vetter's European Clinical Site Successfully Completes First 100 Aseptic Fills
Friday, September 06, 2024Vetter a leading global Contract Development and Manufacturing Organization CDMO has successfully completed the first clinical batches of liquid and lyophilized vials at its dedicated site in Rankweil Austria Vetter Development Services Austria
Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Friday, September 06, 2024Lisata Therapeutics Inc a clinicalstage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases today announced that the US Food and Drug Administration
Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
Thursday, September 05, 2024Pharvaris a latestage biopharmaceutical company developing novel oral bradykinin B receptor antagonists to prevent and treat hereditary angioedema HAE attacks today announced the planned initiation of CHAPTER the pivotal Phase study of deucrictibant
Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial
Thursday, September 05, 2024Outlook Therapeutics Inc a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom earlier this year for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of wet ag...
